当前位置:首页 - 行情中心 - 辰欣药业(603367) - 财务分析 - 现金流量表

辰欣药业

(603367)

  

流通市值:64.80亿  总市值:65.02亿
流通股本:4.51亿   总股本:4.53亿

现金流量表

报告期2023-09-302023-06-302023-03-312022-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
销售商品、提供劳务收到的现金2,858,124,582.81,982,973,782.23955,357,247.483,383,462,944.24
收到的税费返还1,604,245.55325,390.21322,1966,069,580.83
收到其他与经营活动有关的现金43,473,956.5571,591,510.5715,804,769.3495,216,551.51
经营活动现金流入的平衡项目0000
经营活动现金流入小计2,903,202,784.92,054,890,683.01971,484,212.823,484,749,076.58
购买商品、接受劳务支付的现金714,100,756.8445,951,849.77246,930,970.81989,506,456.99
支付给职工以及为职工支付的现金309,031,492.33208,852,660.09100,951,467.09381,716,614.01
支付的各项税费357,934,285.5265,878,623.76142,111,625.23363,185,957.17
支付其他与经营活动有关的现金1,150,970,463.41918,510,305.08381,577,463.111,491,994,443.24
经营活动现金流出的平衡项目0000
经营活动现金流出小计2,532,036,998.041,839,193,438.7871,571,526.243,226,403,471.41
经营活动产生的现金流量净额平衡项目0000
经营活动产生的现金流量净额371,165,786.86215,697,244.3199,912,686.58258,345,605.17
二、投资活动产生的现金流量:
收回投资收到的现金21,240.8221,240.8221,240.82895,211
取得投资收益收到的现金38,243,710.4826,160,187.369,956,857.8136,231,409.89
处置固定资产、无形资产和其他长期资产收回的现金净额443,136265,000-9,000
收到的其他与投资活动有关的现金2,594,458,278.261,845,717,167.57960,842,240.492,660,195,377.75
投资活动现金流入的平衡项目0000
投资活动现金流入小计2,633,166,365.561,872,163,595.75970,820,339.122,697,330,998.64
购建固定资产、无形资产和其他长期资产支付的现金23,474,051.7317,924,729.466,356,436.6735,192,346.36
投资支付的现金10,400,0002,770,000770,000800,000
支付其他与投资活动有关的现金2,929,494,612.612,129,304,556.631,149,837,722.362,934,415,927.59
投资活动现金流出的平衡项目0000
投资活动现金流出小计2,963,368,664.342,149,999,286.091,156,964,159.032,970,408,273.95
投资活动产生的现金流量净额平衡项目0000
投资活动产生的现金流量净额-330,202,298.78-277,835,690.34-186,143,819.91-273,077,275.31
三、筹资活动产生的现金流量:
吸收投资收到的现金5,000,0002,000,000-56,000,000
取得借款收到的现金50,000,00010,000,000-250,000,000
收到其他与筹资活动有关的现金40,964,600.75479,301.2-185,363,280.01
筹资活动现金流入平衡项目00-0
筹资活动现金流入小计95,964,600.7512,479,301.2-491,363,280.01
偿还债务支付的现金50,500,00010,500,000-230,000,000
分配股利、利润或偿付利息支付的现金158,067,696.69155,007,337.611,106,249.99150,743,817.47
其中:子公司支付给少数股东的股利、利润---11,200,000
支付其他与筹资活动有关的现金542,839.66532,979.16433,670.492,425,180.35
筹资活动现金流出平衡项目0000
筹资活动现金流出小计209,110,536.35166,040,316.771,539,920.48383,168,997.82
筹资活动产生的现金流量净额平衡项目0000
筹资活动产生的现金流量净额-113,145,935.6-153,561,015.57-1,539,920.48108,194,282.19
四、汇率变动对现金及现金等价物的影响596,207.82594,349.59-142,429649,153.8
现金及现金等价物净增加额平衡项目0000
五、现金及现金等价物净增加额-71,586,239.7-215,105,112.01-87,913,482.8194,111,765.85
加:期初现金及现金等价物余额997,947,754.62995,682,471.84995,682,471.84901,570,705.99
期末现金及现金等价物余额平衡项目0000
期末现金及现金等价物余额926,361,514.92780,577,359.83907,768,989.03995,682,471.84
补充资料:
净利润-266,887,992.07-352,385,622.34
资产减值准备-3,117,728.62-16,461,766.03
固定资产和投资性房地产折旧-87,078,919.64-220,240,037.66
其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-87,078,919.64-220,240,037.66
无形资产摊销-4,563,335.67-8,327,970.06
长期待摊费用摊销-374,202.69-976,904.72
处置固定资产、无形资产和其他长期资产的损失-1,351,241.65--974,680.16
固定资产报废损失----5,495.43
公允价值变动损失--26,475,958.44-3,119,558.96
财务费用--16,307,914.06-4,520,468.48
投资损失--15,603,427.69--18,679,565.94
递延所得税-4,456,003.63-2,526,156.95
其中:递延所得税资产减少--5,034,919.48--5,065,737.93
递延所得税负债增加-9,490,923.11-7,591,894.88
存货的减少--207,446,133.07-18,097,281.65
经营性应收项目的减少-289,193,578.71--542,341,631.81
经营性应付项目的增加--200,765,633.23-197,674,495.1
其他--10,713,522.79--18,732,949.49
现金的期末余额-780,577,359.83-995,682,471.84
减:现金的期初余额-995,682,471.84-901,570,705.99
公告日期2023-10-272023-08-252023-04-272023-03-31
审计意见(境内)标准无保留意见
TOP↑